Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: December 2009

Chapter 27 - Management of sagittal sinus thrombosis in a child

References

1. AmeriA, BousserMG. Cerebral venous thrombosis. Neurol Clin 1992; 10(1): 87–111.
2. BarnesC, NewallF, FurmedgeJ, MackayM, MonagleP. Cerebral sinus venous thrombosis in children. J Paediatr Child Health 2004; 40(1–2): 53–5.
3. BelmanAL, RoqueCT, AnconaR, AnandAK, DavisRP. Cerebral venous thrombosis in a child with iron deficiency anemia and thrombocytosis. Stroke 1990; 21(3): 488–93.
4. BogousslavskyJ, PierreP. Ischemic stroke in patients under age 45. Neurol Clin 1992; 10(1): 113–24.
5. BonduelM, SciuccatiG, HepnerMet al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003; 73(2): 81–6.
6. BousserMG, ChirasJ, BoriesJ, CastaigneP. Cerebral venous thrombosis – a review of 38 cases. Stroke 1985; 16(2): 199–213.
7. CrassardI, BousserMG. Cerebral venous thrombosis. J Neuroophthalmol 2004; 24(2): 156–63.
8. de BruijnSF, BuddeM, TeunisseS, de HaanRJ, StamJ. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology 2000; 54(8): 1687–9.
9. de BruijnSF, StamJ. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30(3): 484–8.
10. deVeberG, AndrewM, AdamsCet al. (Canadian Pediatric Ischemic Stroke Study Group) Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345(6): 417–23.
11. deVeberG, ChanA, MonaglePet al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998; 55(12): 1533–7.
12. EinhauplKM, VillringerA, MeisterWet al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338(8767): 597–600.
13. FerroJM, CanhaoP, StamJ, BousserMG, BarinagarrementeriaF. (ISCVT Investigators) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35(3): 664–70.
14. FinelliPF, CarleyMD. Cerebral venous thrombosis associated with epoetin alfa therapy. Arch Neurol 2000; 57(2): 260–2.
15. HartfieldDS, LowryNJ, KeeneDL, YagerJY. Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol 1997; 16(1): 50–3.
16. JohnsonMC, ParkersonN, WardS, de AlarconPA. Pediatric sinovenous thrombosis. J Pediatr Hematol Oncol 2003; 25(4): 312–5.
17. KeaneS, GallagherA, AckroydS, McShaneMA, EdgeJA. Cerebral venous thrombosis during diabetic ketoacidosis. Arch Dis Child 2002; 86(3): 204–5.
18. MeenaAK, NaiduKS, MurthyJM. Cortical sinovenous thrombosis in a child with nephrotic syndrome and iron deficiency anaemia. Neurol India 2000; 48(3): 292–4.
19. PreterM, TzourioC, AmeriA, BousserMG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996; 27(2): 243–6.
20. RenowdenS. Cerebral venous sinus thrombosis. Eur Radiol 2004; 14(2): 215–26.
21. SebireG, TabarkiB, SaundersDEet al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005; 128(Pt 3): 477–89.
22. StamJ. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352(17): 1791–8.
23. StamJ, de BruijnSFTM, De VeberG. Anticoagulation for cerebal sinus thrombosis. The Cochrane database of Systematic Reviews 2001; (4): CD002005.
24. van Den BeltAG, PrinsMH, LensingAWet al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2000; (2): CD001100.
25. van GijnJ. Cerebral venous thrombosis: pathogenesis, presentation and prognosis. J Roy Soc Med 2000; 93(5): 230–3.